Matinas BioPharma (NYSEAMERICAN: MTNB) CEO, Jerome D. Jabbour, sits down with WSM’s Jason Lin at NYSE to discuss its lead product candidate, MAT9001, for...
VistaGen Therapeutics (NASDAQ: VTGN) CEO, Shawn Singh, sits down with WSM’s Jason Lin at Nasdaq to discuss the Company’s pipeline of new generation medicines...